









市場行情
/
股票
/
nasdaq-srts
/

Sensus Healthcare Inc

SRTS

3.830USD

-0.010-0.26%

收盤 12/19, 16:00（美東）報價延遲15分鐘

62.97M總市值

虧損本益比TTM



Sensus Healthcare Inc

3.830

-0.010-0.26%

概覽公司財務分析

概覽

公司

財務

分析

關於 Sensus Healthcare Inc 公司

Sensus Healthcare, Inc. is a medical device company that is engaged in the development and delivery of non-invasive treatments for skin cancer and keloids. The Company, leveraging its superficial radiotherapy (SRT and IG-SRT) technology, provides healthcare providers with a patient-centric treatment platform. Its products and services include SRT-100, SRT-100 Vision, SRT-100+, Sentinel service program and others. The SRT-100 is a photon x-ray low energy SRT system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides customers with additional options compared to the SRT-100 base model. These additional options allow for dedicated treatment planning and full treatment progression documentation in a patient’s record. The SRT-100+ offers all the same features as the SRT-100, with the addition of remote diagnostics and other features.

Sensus Healthcare Inc簡介



公司代碼SRTS

公司名稱Sensus Healthcare Inc

上市日期Jun 03, 2016

CEOSardano (Joseph C)

員工數量35

證券類型Ordinary Share

年結日Jun 03

公司地址851 Broken Sound Pkwy NW Ste 215

城市BOCA RATON

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United States of America

郵編33487-3635

電話15619225808

網址https://sensushealthcare.com/

公司代碼SRTS

上市日期Jun 03, 2016

CEOSardano (Joseph C)

Sensus Healthcare Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Joseph C. Sardano

Chairman of the Board, Chief Executive Officer, Co-Founder

1.20M

+2.13%

Mr. Eric Sachetta

Independent Director

140.11K

Mr. Javier Rampolla

Chief Financial Officer

40.00K

-1.82%

Ms. Megan Cornish

Non-Employee Independent Director

32.00K

Ms. Magdalena Martinez

Chief Operating Officer

15.01K

+53.84%

Mr. Emiliano Sosa

Chief Technology Officer

10.00K

Mr. Anthony B. Petrelli

Non-Employee Independent Director

Mr. Michael J. Sardano, J.D.

President, General Counsel, Corporate Secretary, Chief Commercial Officer, Director

名稱

名稱/職務

職務

持股

持股變動

Mr. Joseph C. Sardano

Chairman of the Board, Chief Executive Officer, Co-Founder

1.20M

+2.13%

Mr. Eric Sachetta

Independent Director

140.11K

Mr. Javier Rampolla

Chief Financial Officer

40.00K

-1.82%

Ms. Megan Cornish

Non-Employee Independent Director

32.00K

Ms. Magdalena Martinez

Chief Operating Officer

15.01K

+53.84%

Mr. Emiliano Sosa

Chief Technology Officer

10.00K

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Product Revenue

5.75M

78.58%

Service Revenue

1.57M

21.42%

地區USD

名稱

營收

佔比

United States

6.71M

91.76%

China

587.00K

8.02%

others

16.00K

0.22%

業務

地區

業務USD

名稱

營收

佔比

Product Revenue

5.75M

78.58%

Service Revenue

1.57M

21.42%

股東統計

更新時間: 11月26日週三

持股股東

股東類型

持股股東

佔比

Solot (Edwin L)

7.58%

Sardano (Joseph C)

7.31%

The Vanguard Group, Inc.

4.44%

Pacific Ridge Capital Partners, LLC

3.49%

Dimensional Fund Advisors, L.P.

3.47%

其他

73.72%

持股股東

佔比

Solot (Edwin L)

7.58%

Sardano (Joseph C)

7.31%

The Vanguard Group, Inc.

4.44%

Pacific Ridge Capital Partners, LLC

3.49%

Dimensional Fund Advisors, L.P.

3.47%

其他

73.72%

股東類型

持股股東

佔比

Individual Investor

18.26%

Investment Advisor

14.03%

Investment Advisor/Hedge Fund

11.46%

Hedge Fund

1.76%

Pension Fund

1.61%

Research Firm

0.28%

Family Office

0.08%

其他

52.51%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

125

4.72M

28.74%

-1.24M

2025Q2

140

7.09M

43.13%

-2.09M

2025Q1

154

7.13M

43.39%

-2.80M

2024Q4

147

7.94M

48.11%

-1.27M

2024Q3

150

7.10M

43.29%

-2.85M

2024Q2

154

6.60M

40.18%

-2.53M

2024Q1

151

6.11M

37.21%

-3.18M

2023Q4

151

6.25M

38.07%

-3.71M

2023Q3

150

6.30M

38.34%

-3.97M

2023Q2

150

6.99M

42.55%

-3.21M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Solot (Edwin L)

1.25M

7.57%

-288.00K

-18.78%

Dec 31, 2024

Sardano (Joseph C)

1.18M

7.15%

Apr 10, 2025

The Vanguard Group, Inc.

740.02K

4.5%

Jun 30, 2025

Pacific Ridge Capital Partners, LLC

454.76K

2.77%

+340.26K

+297.17%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

602.48K

3.66%

+60.75K

+11.21%

Jun 30, 2025

Divisadero Street Capital Management, LP

324.67K

1.97%

+266.63K

+459.41%

Jun 30, 2025

Florida State Board of Administration

189.67K

1.15%

+122.09K

+180.67%

Jun 30, 2025

Renaissance Technologies LLC

250.13K

1.52%

-9.50K

-3.66%

Jun 30, 2025

Driehaus Capital Management, LLC

237.91K

1.45%

+53.67K

+29.13%

Aug 31, 2025

Acadian Asset Management LLC

377.41K

2.3%

-93.31K

-19.82%

Jun 30, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

iShares Micro-Cap ETF

0.01%

DFA Dimensional US Sustainability Core 1 ETF

Dimensional US Core Equity 1 ETF

Avantis US Small Cap Value ETF

DFA Dimensional US Small Cap Value ETF

Avantis US Small Cap Equity ETF

Lattice Hartford Multifactor Small Cap ETF

iShares Micro-Cap ETF

佔比0.01%

DFA Dimensional US Sustainability Core 1 ETF

佔比0%

Dimensional US Core Equity 1 ETF

佔比0%

Avantis US Small Cap Value ETF

佔比0%

DFA Dimensional US Small Cap Value ETF

佔比0%

Avantis US Small Cap Equity ETF

佔比0%

Lattice Hartford Multifactor Small Cap ETF

佔比0%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

Sensus Healthcare Inc的前五大股東是誰？



Sensus Healthcare Inc的前五大股東如下：
Solot (Edwin L)
持有股份：1.25M
佔總股份比例：7.57%。
Sardano (Joseph C)
持有股份：1.18M
佔總股份比例：7.15%。
The Vanguard Group, Inc.
持有股份：740.02K
佔總股份比例：4.50%。
Pacific Ridge Capital Partners, LLC
持有股份：454.76K
佔總股份比例：2.77%。
Dimensional Fund Advisors, L.P.
持有股份：602.48K
佔總股份比例：3.66%。